All Activity

A GOP senator attended a ribbon cutting ceremony for a Kentucky hemp business on Monday, where he again previewed a forthcoming bill to regulate the crop as an alternative to its pending recriminalization under legislation that President Donald Trump signed last month. Sen. Rand Paul (R-KY) spoke about hemp policy issues and his plan to avert the new federal ban, which is set to take effect next November, at an event marking the opening of a Cornbread Hemp location in Louisville. When hemp’s potential federal legalization was being considered as part of the 2018 Farm Bill that Trump signed in his first term, Paul said he thought that’d be “great,” particularly for Kentucky farmers who’ve seen losses as demand for tobacco has decreased. Creating a cannabis industry would also support ancillary businesses that aren’t plant-touching, he said. Hemp legalization has been a “great success,” Paul added, “and I don’t want government to stifle this” He also addressed arguments supporting the hemp ban that he described as “untrue,” including the idea that all cannabinoid products are being sold at gas stations and marketed in a way that targets youth. Kentucky—which enacted a regulatory framework for hemp that aims to mitigate those issues—is an example of how cannabis products can be responsibly sold to adult consumers, Paul said. I joined Cornbread Hemp at their ribbon cutting for their newest facility in Louisville. I am fighting to stop this industry-ending ban and standing up for our farmers. Thank you for having me, @CornbreadHemp. — Senator Rand Paul (@SenRandPaul) December 16, 2025 “I am worried about the legislation,” the senator added, referencing the appropriations measure that Trump signed last month with hemp ban provisions left intact despite Paul’s efforts to remove them. “We are working on new legislation, but I’ve got to convince my colleagues to change their opinion.” “I think one of the ways we may be able to get this new legislation passed is simply not to set exact federal parameters, but to say, ‘look, if your state already regulates hemp, why don’t we let your state make these decisions—not the federal government. There still will be the question of going across state lines we have to tackle. We’re in the process of listening to people in the business, listening to the farmers and trying to come to some conclusion that we’ve got to change their minds. We have about a year.” The senator—who laid partial blame for the pending hemp ban on alcohol and marijuana interests—also made the case that text of the recently enacted spending bill would effectively prohibit the sale of not just consumable cannabinoid products but also plants used for “non-edible purposes” such an clothing and building materials. That reflects the “idiocy” of the measure, he said. Paul pointed to Cornbread Hemp as a business that would likely be unfairly impacted by the hemp policy change, and he said the opening of its latest facility is “good for Louisville” to support consumers and promote job creation. “I think we should be open-minded to allowing adults to choose what they would like to take for a variety of conditions. And, apparently, millions of people think this is helpful to them–and then some simply use it as a drink to feel some effect as maybe having a beer,” Paul said. “But I’m proud of the companies.” Today, Sen. @RandPaul cut the ribbon to officially open the @CornbreadHemp retail store and public tours. pic.twitter.com/8GKVwLmd1W — Jim Higdon (@jimhigdon) December 16, 2025 Paul has been sounding the alarm for weeks about the potential consequences of the hemp recriminalization provisions, which he said would cause mass job losses and a $25 billion industry to be “wiped out.” The senator initially said he’d be imminently filing a bill to address the issue last month, describing the legislation during a webinar organized by the Kentucky Hemp Association. So far, the text has not been released, but Paul said it would make it so state policy regulating hemp cannabinoid products—with basic safeguards in place to prevent youth access, for example—”supersedes the federal law.” “I like the approach of doing it [this way], because it’s not a direct repeal, and we’re [doing] an end-run around him,” Paul said. “And if a state doesn’t have laws—and they want to have a hemp industry—they’d get pretty busy at their state legislature and go ahead and put something in place so they can have a hemp industry, because I don’t think you can have one under [Senate Majority Leader Mitch McConnell’s (R-KY)] law.” Stakeholders say the new definition will devastate the market, as even non-intoxicating CBD items typically exceed the proposed 0.4 mg THC per container limit that is set to be enforced around this time next year. Since a majority of his colleagues in the Senate opted to advance the appropriations bill, however, “now I’m asking them to repeal something they’ve already voted for,” Paul said. “But if I ask them to vote for language that lets their state make the decision on regulation, we might get more votes.” Opposition to the ban crosses party lines, too. For example, Sens. Ron Wyden (D-OR) and Jeff Merkley (D-OR) introduced a bill last week to create a federal regulatory framework for hemp-derived cannabinoids and allow states to set their own rules for products such as CBD. The measure is conceptually similar to what Paul previewed about his own legislation, but it also includes additional prescriptive regulatory controls that may conflict with the GOP senator’s more libertarian principles. On the other end of the debate, Rep. Andy Harris (R-MD), who helped secure the hemp re-criminalization language, said last month that he’s not concerned about attempts to undercut the enacted law, brushing off arguments about the possible consequences of the policy change as “desperate mistruths from an industry that stands to lose billions of dollars by selling intoxicants to children.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Overall, there’s been widespread outcry over the pending hemp re-criminalization law, drawing criticism from parents of cannabis patients, veterinarians and influencers like Joe Rogan, for example. In response to the hemp ban, Rep. Nancy Mace (R-SC) filed a bill that would strike the contested provisions of the appropriations legislation. But some stakeholders worry that approach could backfire, and they’re hoping to see bipartisan bills introduced in he near future that would provide a robust regulatory model for intoxicating hemp products as a viable alternative to blanket prohibition. Meanwhile, GOP political operative Roger Stone said last month that Trump was effectively “forced” by Republican lawmakers to sign the spending bill with the hemp THC ban language. However, a White House spokesperson said prior to the bill signing that Trump specifically supported the prohibition language. The Democratic governor of Kentucky said last month that the hemp industry is an “important” part of the economy that deserves to be regulated at the state level—rather than federally prohibited, as Congress has moved to do. Also, a leading veterans organization is warning congressional leaders that the newly approved blanket ban on consumable hemp products could inadvertently “slam the door shut” on critical research. While many hemp stakeholders say the ban would effectively eradicate the industry–even applying to nonintoxicating CBD products that people use for medical reasons—there’s latent hope that they can strike a compromise deal with lawmakers before the prohibition is implemented this time next year. Lawmakers such as Sen. Chris Van Hollen (D-MD) also say that window could provide an opportunity to advance legislation to create an alternative regulatory model for consumable hemp products. Since 2018, cannabis products have been considered legal hemp if they contain less than 0.3 percent delta-9 THC on a dry weight basis. The new legislation specifies that, within one year of enactment, the weight will apply to total THC—including delta-8 and other isomers. It will also include “any other cannabinoids that have similar effects (or are marketed to have similar effects) on humans or animals as a tetrahydrocannabinol (as determined by the Secretary of Health and Human Services).” The new definition of legal hemp will additionally ban “any intermediate hemp-derived cannabinoid products which are marketed or sold as a final product or directly to an end consumer for personal or household use” as well as products containing cannabinoids that are synthesized or manufactured outside of the cannabis plant or not capable of being naturally produced by it. Legal hemp products will be limited to a total of 0.4 milligrams per container of total THC or any other cannabinoids with similar effects. Within 90 days of the bill’s enactment, the Food and Drug Administration (FDA) and other agencies will need to publish list of “all cannabinoids known to FDA to be capable of being naturally produced by a Cannabis sativa L. plant, as reflected in peer reviewed literature,” “all tetrahydrocannabinol class cannabinoids known to the agency to be naturally occurring in the plant” and “all other known cannabinoids with similar effects to, or marketed to have similar effects to, tetrahyrocannabinol class cannabinoids.” The language slightly differs from provisions included in legislation that had previously advanced out of the House and Senate Appropriations panels, which would have banned products containing any “quantifiable” amount of THC, to be determined by the HHS secretary and secretary of agriculture. The post GOP Senator Attends Hemp Business Ribbon Cutting Ceremony, Vowing To Fight To Stop Looming Federal THC Product Ban appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Under the new rules, business will have to reveal any agreements “that affect ownership, control or financial interests in cannabis operations.” By Rebecca Rivas, Missouri Independent Missouri cannabis regulators have routinely revoked microbusiness licenses for relying on contracts they’ve publicly characterized as “predatory.” The state is hoping to put a stop to the turnover through proposed rules that will be open for public comment starting Monday through January 14. Regulators first introduced the rules last December and have since held two opportunities for public input, before submitting them to the Missouri Secretary of State in November. The microbusiness program—sometimes called the social-equity cannabis program—was designed to boost opportunities in the industry for people in disadvantaged communities that have been most impacted by the war on drugs. It began in 2023, after passing as part of the constitutional amendment to legalize recreational marijuana in 2022. For the last two years, The Independent has documented a pattern of well-connected groups and individuals flooding the microbusiness lottery by recruiting people to submit applications and then offering them contracts that limit their profit and control of the business. Of the 105 microbusiness licenses issued so far, 35 have been revoked, including 22 that involved contracts drafted by St. Louis-based Armstrong Teasdale law firm. In order to prevent the continued cascade of revocations, the Missouri Division of Cannabis Regulation is proposing to adjust when its extensive application-review period occurs. The point when regulators would review questionable contracts would take place before the license is issued, instead of afterwards as it is now. The rules would also be changed to clarify that “owners, agents or representatives” of a microbusiness application or license that regulators have denied or revoked would be prohibited from holding a voting or financial interest in any other microbusiness license. The designated-contact role was envisioned as a way to ensure clear communication between the state and licensees. However, regulators found in their investigations that designated contacts have kept the actual eligible applicants in the dark about business and license dealings. The new rules would require the designated contact for a microbusiness applicant to be a majority owner of the microbusiness license. According to court documents, some applicants of the revoked licenses told regulators they were going to be “one of three managers,” leaving them without majority voting power in the business. And they did not demonstrate they had “a credible intent or ability to be the majority owner and operator” of the business, regulators found. Under the new rules, “majority owned and operated” would be defined as the eligible individuals who are listed as having majority ownership must have a level of operational control that would be expected of an owner. Eligible individuals must have the power to order or direct the management, managers and policies of the license, enter into agreements on behalf of the license and otherwise make decisions for the business. “A purported owner with little to no knowledge, control, agency or decision-making authority in an application or license does not meet the intent or meaning of the” constitutional amendment that created the microbusiness program, according to the press release the division issued when it introduced the rules last year. Applicants would also be required to take an online training course that addresses predatory practices and funding opportunities. The division expects to file the final version of rule amendments for formal rulemaking in early 2026, prior to the third round of microbusiness licensing. The contracts An investigation by The Independent in October revealed that the attorney who crafted most contracts at the heart of the recent license revocations also represents the marijuana industry trade group. Eric Walter is a St. Louis-based attorney who represents the Missouri Cannabis Trade Association and a significant percentage of the state’s cannabis licensees. He wrote 22 agreements the state believes would take the microbusiness licenses out of the hands of eligible applicants and put them into the hands of well-connected or out-of-state cannabis investors, according to the administrative appeal case documents obtained by The Independent. Each of those agreements largely led to the state revoking a microbusiness license issued last year for not meeting the constitutional mandate that the licenses be “majority owned and operated” by eligible applicants. All but one of the license revocations is being appealed to the Missouri Administrative Hearing Commission. To be eligible for a microbusiness license, applicants must meet certain criteria, including income below certain thresholds, having past marijuana offenses or being a disabled veteran. The contracts written by Walter gave applicants two years to pay back loans that can total up to $2 million. If they couldn’t, they’d have to pay a “break-up fee” of up to $2.5 million or give up ownership of the license transfers to the loan holder, according to the state’s response in several of the appeals. “Therefore, the business would likely be unable to generate revenue to pay back the loan,” the state argues in one of the legal filing responding to a revocation appeal. “This leaves them no option but to convert the debt into ownership.” In most cases, the same people involved in the consulting company that hired Armstrong Teasdale to draw up the contract are also involved in lending the money. Walter’s law firm and the consulting companies who hired the firm to draw up the agreements have vehemently denied the contracts are predatory, arguing the applicants voluntarily signed them. “Those documents are all transparent, fair and compliant with Missouri law, including the Department of Health and Senior Services’ rules,” Jamie Moss, spokeswoman for Walter’s law firm, Armstrong Teasdale, said in an email to The Independent in October. Under the new rules, regulators will specifically ask for any business agreements related to the license “that affect ownership, control or financial interests in cannabis operations,” including all management agreements, consulting agreements, partnership agreements, loans, “or other agreements whereby any entities stand to gain financially from the business.” This story was first published by Missouri Independent. The post Missouri Marijuana Officials File Proposed Rules Targeting ‘Predatory’ Contracts For Equity Businesses appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A GOP congressman says President Donald Trump would “wrong” to move forward with a plan to reschedule marijuana, which he described as a “gateway drug” that leads to the use of “harder substances”—despite numerous studies contradicting that theory. The cannabis community is waiting with bated breath for Trump to make a decision on a proposal to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA). He said in August that there’d be a decision within weeks, and on Monday he said the administration was looking “very strongly” at the issue. Rep. Mike Lawler (R-NY) was asked about the potentially imminent reform during an interview with NewsNation’s “The Hill” that aired on Monday. And the congressman said it would be a bad idea, even though rescheduling would not federally legalize cannabis. Part of his thinking is rooted in the debunked “gateway drug” theory. Lawler also argued that there’s a policy disconnect between the administration’s aggressive anti-drug campaign ostensibly focused on fentanyl and the reported plans to reschedule marijuana, which Trump said on Monday would remove research barriers to study the plant. “If you look at the reason that we went after the cartels and labeled them foreign terrorist organizations, it’s because over 75,000 Americans are dying on an annual basis from fentanyl overdoses,” Lawler said. “Most of the drugs laced with fentanyl are coming across the border. And so [Trump is] right to go after that.” “He’s right to go after fentanyl. That is what is killing many Americans on an annual basis,” the congressman said. “But I think rescheduling marijuana is wrong. The fact is, marijuana is a gateway drug. Most of the people [who] end up using harder substances start out on marijuana.” He also echoed a common prohibitionist talking point about the potential health risks associated with using high-THC marijuana products. “The THC content in marijuana is significantly higher today than it was 30, 40 years ago,” he said, “and so when you look at the challenges that we’re facing as a country with substance use disorder, I don’t think rescheduling marijuana is wise. I’m opposed to that.” “I think we need to work to address the fact that we have a demand issue in this country. We need to help people get the support that they need—simultaneously going after the dealers and those, certainly, who push fentanyl-based products,” Lawler added. It remains to be seen whether Trump will ultimately fulfill his campaign promise to move cannabis to Schedule III, which would not legalize the plant but would let marijuana businesses take federal tax deductions while removing certain research barriers. He endorsed rescheduling—as well as industry banking access and a Florida adult-use legalization initiative—on the campaign trail last year. But he’s since been largely silent on the issue since taking office during his second term, until a briefing in August where in response to a reporter’s question he announced the administration would decide on rescheduling within weeks. Meanwhile, multiple top congressional Democrats are making the case that the modest reform would not go far enough—including Sen. Ron Wyden (R-OR) who said the move is only an attempt by the president to “gaslight” voters into thinking he legalized cannabis to boost his “pathetic” approval ratings. A major drug testing industry organization separately said it’s “sounding the alarm” amid the reports Trump may soon finalize the rescheduling proposal, arguing that the policy change would “have catastrophic consequences for the safety of the United States workforce and transportation sectors.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Cannabis industry stakeholders are holding out hope that the reform will be achieved as soon as possible, but opponents—including the National Drug & Alcohol Screening Association (NDASA) and Smart Approaches to Marijuana (SAM)—are working to dissuade the administration before a final decision is made. For what it’s worth, a White House spokesperson told Marijuana Moment last week that no actions have been finalized so far. Bipartisan congressional lawmakers have been weighing in on the potential rescheduling decision over the past week—with Democrats like Rep. Alex Ocasio-Cortez (D-NY) calling the reform a “no-brainer” and others like Rep. Andy Harris (R-MD) pushing back against the proposal. The Washington Post reported last week that Trump was planning to issue an executive order directing federal agencies to move ahead with cannabis rescheduling. The outlet also said the president met earlier this week in the Oval Office with marijuana industry executives, Health and Human Services Secretary Robert F. Kennedy Jr. and Centers for Medicare and Medicaid Services Administrator Mehmet Oz. During that meeting, Trump phoned Johnson, the House speaker, who expressed his opposition to rescheduling cannabis, If the administration does ultimately enact rescheduling, it would mark one of the most significant developments in federal marijuana policy since its prohibition a half a century ago, with a Schedule III reclassification recognizing that marijuana has medical value and a lower abuse potential compared to other Schedule I drugs like heroin. Photo courtesy of Chris Wallis // Side Pocket Images. The post Trump Would Be ‘Wrong’ To Reschedule ‘Gateway Drug’ Marijuana, GOP Congressman Says As Reform Rumors Spread appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A coalition of anti-marijuana organizations is urging the U.S. Supreme Court to side with the federal government by upholding the constitutionality of a federal ban on gun ownership by people who use cannabis—which they claim is associated with violence and psychosis. In an amicus brief submitted to justices on Monday for a marijuana and firearms case, U.S. v. Hemani, Smart Approaches to Marijuana (SAM) and 21 other prohibitionist groups said that while cannabis is “marketed as a ‘chill’ drug by its peddlers,” today’s product has “become increasingly known for its relationship with violence.” “Given the shared national work amici are doing to stop the flow of drugs and their harms to society, they have a strong interest in laws restricting drug users’ access to firearms,” the brief said. “The evidence is clear: today’s highly potent marijuana causes psychosis, schizophrenia, other forms of severe mental illness, and violent behavior.” It added that if the federal statute known as 922(g)(3) is deemed unconstitutional—as multiple federal courts have determined in the lead-up to SCOTUS taking the Hemani case—would “magnify these harms exponentially and devastate America’s families.” The overarching argument of the brief is the idea that marijuana is strongly linked to mental illness, which may make a more compelling reason to maintain the gun ban given the need to establish a historical, legal analogue going back to the country’s founding under recent Supreme Court precedent. “Marijuana is thus strongly associated with long-lasting mental illness,” it said. “This court has already recognized that mental illness is a compelling reason to restrict gun ownership.” But the prohibitionist organizations’ brief raised eyebrows for another reason: It claimed marijuana use is more dangerous to society and a person’s mental health than alcohol, despite conflicting data from studies the filing did not cite. “Unlike alcohol use, marijuana use has long had a documented, causal relationship with schizophrenia and psychosis,” it said. “Alcohol’s relationship with mental distress typically ends when the user is no longer feeling its effects. Marijuana’s relationship with mental illness is often only getting started there: When regular marijuana users develop cases of schizophrenia or psychosis, these ailments often endure.” The point echoes a recent filing from the Justice Department itself in Hemani, with U.S. Solicitor General D. John Sauer advising justices that people who use illegal drugs “pose a greater danger” than those who drink alcohol. In addition to SAM, the new brief was also signed by Americans Against Legalizing Marijuana, Cannabis Industry Victims Educating Litigators, CADCA, Drug Watch International Inc., Drug Free America Foundation, Save Our Society from Drugs, National Families in Action and 14 other groups. “The state-level legalization of marijuana has spawned big business, with large corporations competing to create stronger products designed to addict users,” they said. “As marijuana has become a competitive, commercialized product, its potency has soared, leading to substantial harm to public health and safety.” “The drug has thus become much more deleterious to mental health: Marijuana use is now a leading risk factor for schizophrenia, psychosis, and other forms of mental illness,” the brief continues. “Marijuana is now also a common denominator in many instances of gun violence. Because of marijuana’s causal relationship with an increased risk of mental illness and violence, this Court should affirm the federal prohibition on drug users owning firearms.” The DOJ and amicus briefs were filed as rumors swell that President Donald Trump intends to issue an executive order directing federal agencies to reclassify marijuana, moving it from Schedule I to Schedule III of the Controlled Substances Act (CSA). Whether that happens is yet to be seen. Meanwhile, the Biden administration was evidently concerned about potential legal liability in federal cases for people convicted of violating gun laws simply by being a cannabis consumer who possessed a firearm, documents recently obtained by Marijuana Moment show. The previously unpublished 2024 guidance from former President Joe Biden’s Justice Department generally cautioned U.S. attorneys to use discretion in prosecuting federal cannabis cases, particularly for offenses that qualified people for pardons during his term. But one section seems especially relevant as the Supreme Court takes on a case challenging the constitutionality of the current federal gun statute. With respect to Hemani, in a separate August filing for the case, the Justice Department also emphasized that “the question presented is the subject of a multi-sided and growing circuit conflict.” In seeking the court’s grant of cert, the solicitor general also noted that the defendant is a joint American and Pakistani citizen with alleged ties to Iranian entities hostile to the U.S., putting him the FBI’s radar. Now that the Supreme Court has agreed to take up Hemani, if justices declare 922(g)(3) constitutional, such a ruling could could mean government wins in the remaining cases. The high court last month denied a petition for cert in U.S. v. Cooper, while leaving pending decisions on U.S. v. Daniels and U.S. v. Sam. The court also recently denied a petition for cert in another gun and marijuana case, U.S. v. Baxter, but that wasn’t especially surprising as both DOJ and the defendants advised against further pursing the matter after a lower court reinstated his conviction for being an unlawful user of a controlled substance in possession of a firearm. Meanwhile, in recent interviews with Marijuana Moment, several Republican senators shared their views on the federal ban on gun possession by people who use marijuana—with one saying that if alcohol drinkers can lawfully buy and use firearms, the same standard should apply to cannabis consumers. Separately, the U.S. Court of Appeals for the Tenth Circuit earlier this year sided with a federal district court that dismissed an indictment against Jared Michael Harrison, who was charged in Oklahoma in 2022 after police discovered cannabis and a handgun in his vehicle during a traffic stop. The case has now been remanded to that lower court, which determined that the current statute banning “unlawful” users of marijuana from possessing firearms violates the Second Amendment of the Constitution. The lower court largely based his initial decision on an interpretation of a Supreme Court ruling in which the justices generally created a higher standard for policies that seek to impose restrictions on gun rights. Separately, in the U.S. Court of Appeals for the Eleventh District, judges recently ruled in favor of medical cannabis patients who want to exercise their Second Amendment rights to possess firearms. As a recent report from the Congressional Research Service (CRS) explained the current legal landscape, a growing number of federal courts are now “finding constitutional problems in the application of at least some parts” of the firearms prohibition. In a recent ruling, a three-judge panel for the U.S. Court of Appeals for the Eighth Circuit vacated a defendant’s conviction and remanded the case back to a district court, noting that a retrial before a jury may be necessary to determine whether cannabis in fact caused the defendant to be dangerous or pose a credible threat to others. The Third Circuit separately said in a published opinion that district courts must make “individualized judgments” to determine whether 922(g)(3) is constitutional as applied to particular defendants. A federal court in October agreed to delay proceedings in a years-long Florida-based case challenging the constitutionality of the ban on gun ownership by people who use medical marijuana, with the Justice Department arguing that the Supreme Court’s recent decision to take up Hemani warrants a stay in the lower court. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Earlier this year, a federal judge in Rhode Island ruled that the ban was unconstitutional as applied to two defendants, writing that the government failed to establish that the “sweeping” prohibition against gun ownership by marijuana users was grounded in historical precedent. A federal judge in El Paso separately ruled late last year that the government’s ongoing ban on gun ownership by habitual marijuana users is unconstitutional in the case of a defendant who earlier pleaded guilty to the criminal charge. The court allowed the man to withdraw the plea and ordered that the indictment against him be dismissed. DOJ has claimed in multiple federal cases over the past several years that the statute banning cannabis consumers from owning or possessing guns is constitutional because it’s consistent with the nation’s history of disarming “dangerous” individuals. In 2023, for example, the Justice Department told the U.S. Court of Appeals for the Third Circuit that historical precedent “comfortably” supports the restriction. Cannabis consumers with guns pose a unique danger to society, the Biden administration claimed, in part because they’re “unlikely” to store their weapon properly. Meanwhile, some states have passed their own laws either further restricting or attempting to preserve gun rights as they relate to marijuana. Recently a Pennsylvania lawmaker introduced a bill meant to remove state barriers to medical marijuana patients carrying firearms. Colorado activists also attempted to qualify an initiative for November’s ballot that would have protected the Second Amendment rights of marijuana consumers in that state, but the campaign’s signature-gathering drive ultimately fell short. As 2024 drew to a close, the ATF issued a warning to Kentucky residents that, if they choose to participate in the state’s medical marijuana program that’s set to launch imminently, they will be prohibited from buying or possessing firearms under federal law. The official said that while people who already own firearms aren’t “expected to” turn them over if they become state-legal cannabis patients, those who “wish to follow federal law and not be in violation of it” must “make the decision to divest themselves of those firearms.” Since then, bipartisan state lawmakers have introduced legislation that would urge Kentucky’s representatives in Congress to amend federal law to clarify that users of medical marijuana may legally possess firearms, though no action has since been taken on that bill. Kentucky Gov. Andy Beshear (D) said in January that he supported the legislature’s effort to urge the state’s congressional delegation to call for federal reforms to protect the Second Amendment rights of medical marijuana patients, but the governor added that he’d like to see even more sweeping change on the federal level. The post Marijuana Isn’t ‘Chill’ And Is Actually More Dangerous Than Alcohol, Anti-Legalization Groups Tell Supreme Court In Brief For Gun Rights Case appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Elite athletes find cannabidiol, or CBD, useful for soreness and recovery, a new study shows. Researchers found that top competitors use CBD to manage pain, improve sleep and ease the stress of training at the highest level. But the results suggest that even as many athletes believe the cannabis compound helps them recover, they also worry that using it could jeopardize their careers under international anti-doping rules. The study, conducted between late 2021 and mid-2023 and published this month in the journal Frontiers in Nutrition, surveyed 80 elite Canadian athletes across 27 national sport organizations. To be included, athletes needed to have experience as part of the country’s Olympic or Paralympic team program. About 38 percent reported using CBD at some point, and nearly a third of those said they were still using it at the time of the survey. The participants’ motivations reflect a broader societal trend of relying on CBD for therapeutic benefit. The study found that 96 percent of CBD users said they believed the substance was safe, 93 percent said it improved their sleep, 90 percent said it helped them relax and 77 percent credited it with reducing pain from training. “Thirty eight percent of athletes self-reported using CBD, and cumulatively agreed or strongly agreed that CBD improved sleep and relaxation, reduced pain from training, and enhanced physical and mental recovery following training or competition.” Despite the reported benefits, CBD use among athletes remains a controversial topic. Although the World Anti-Doping Agency removed CBD from its list of banned substances in 2018, all other cannabinoids—including THC—remain prohibited. This creates conditions the authors describe as “a fine line between unintentional doping and intentional use of cannabis products.” Because many commercially available CBD products contain trace levels of these banned compounds, athletes who rely on them may be risking inadvertent doping violations. That concern, researchers found, was the single most common reason athletes chose not to try CBD or stopped using it altogether. The authors, affiliated with McGill University and the Canadian Sport Institute, also noted that “some CBD-fortified foods and beverages have been reported to convert CBD into THC under low pH conditions…potentially yielding sufficient THC (3 mg) to trigger a positive urine test for prohibited cannabinoids.” They further observed that physical exertion prior to testing may increase detectable THC levels. Altogether, the situation puts athletes in a kind of limbo. Those who feel genuine relief from CBD are left to navigate a market where product labels can’t always be trusted and scientific guidance remains sparse. Many said they first heard about CBD through friends or online, not from sports physicians or trainers. “Many athletes expressed concerns about the potential for inadvertent anti-doping rule violations due to CBD product contamination with THC or other banned cannabinoids.” “Given that athletes frequently reported obtaining information on CBD from friends and online sources,” the authors wrote, “there is also a need to test interventions that enhance evidence-based knowledge among both athletes and clinicians.” The study comes following sports leagues in the U.S. taking steps to update their marijuana policies as legalization becomes more widespread, including the National Collegiate Athletic Association (NCAA) and the National Football League (NFL). An NFL-funded study from 2024 found that marijuana use is becoming more widely accepted among athletes. The authors of that paper noted that “education and awareness on benefits and potential harm is needed for athletes, medical staff, and policymakers.” Meanwhile, the Major League Baseball (MLB) removed marijuana from its list of banned substances in 2019. The National Basketball Association followed suit in 2023. The post CBD Provides Pain Relief, Improves Sleep And Aids Relaxation, Study Involving Olympic Athletes Shows appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

a extremely superb webpage. a realy educational in addition to a an extremely superior position. i’m a sucker for the. Arquitectura

Remarkable content, decided in front of you and additionally book marked your blog post. Document can’t simply wait to read a great deal more right from you will. Construccion

House Renovations Perth works with excellent, high-quality suppliers, We offer the best in kitchen materials. Whether you want a stone counter top, high-end wood cabinets, or the best industrial oven money can buy, we can arrange it. House Renovations Perth

A congressional committee has advanced a bill aimed at protecting children online that could create complications for advertisers trying to promote legal marijuana and other regulated substances. Rep. Gus Bilirakis (R-FL) filed the Kids Online Safety Act (KOSA) earlier this month, and the House Energy and Commerce Subcommittee on Commerce, Manufacturing, and Trade approved an amended version of the legislation on Thursday on a party-line vote of 13-10, with Republicans in support and Democrats in opposition. Bipartisan senators introduced a version of the measure earlier this year, but it has not advanced in that chamber this Congress even though a prior iteration was passed by the body in 2024. Under the new legislation, online platforms would be prohibited from facilitating the “advertising of narcotic drugs, cannabis products, tobacco products, gambling, or alcohol to an individual that the covered platform knows is a minor.” The provision around drug use lists the “distribution, sale, or use of narcotic drugs, tobacco products, cannabis products, gambling, or alcohol” as risks that platforms would need to actively guard minors against. One section that was in prior iterations of the bill that seems to have been omitted from this latest version had stipulated that video streaming platforms would be required “to employ measures that safeguard against serving advertising for narcotic drugs, cannabis products, tobacco products, gambling, or alcohol directly to the account or profile of an individual that the service knows is a minor.” It’s unclear why that language was left out of the new measure. Online platforms covered under the legislation under those that are publicly available for use, allow the creation of searchable usernames that can be followed, facilitate the “share and access to user-generated content,” is designed to promote engagement and uses user information to target advertising. Bilirakis, who chairs the House panel that approved his amended legislation last week, said the bill “protects kids across America by mandating default safeguards and easy-to-use parental controls to empower families.” “It is the foundation and the safety net, with concrete safeguards to keep kids and teens safe,” he said. Few in the public policy space oppose the intent of the legislation, but some say its broad and potentially vague requirements could be difficult in practice. Shoshana Weismann, a fellow at the free-market R Street Institute, told Marijuana Moment earlier this year when the Senate version was filed that the measure could ultimately block wide swaths of online advertising that are accessible by minors—even if the ads don’t target children, as the bill’s proponent’s suggest. “The problem is that the knowledge standard here is so loose,” she said, pointing to the bill’s definition of knowledge by platforms that they’re serving content to underage users. Another previous version of KOSA, introduced in the 118th Congress, won Senate approval last summer but did not pass out of the House. After last year’s Senate passage of the measure, Jenna Leventoff, ACLU’s senior policy council and director of the civil right’s group’s national political advocacy division, said she was skeptical the legislation would pass constitutional muster. A number of states have attempted to adopt bills similar to KOSA, Leventoff pointed out, and “in almost every case, a court has evaluated those laws and determined that they are likely to be unconstitutional.” “It’s extremely likely that KOSA is unconstitutional,” she said at the time,” and it makes me wonder why Congress is trying to enact something that won’t hold up in a court of law.” At the state level last year, Colorado’s Senate passed a bill similarly aimed at protecting minors from drug and other controversial content. But the proposal—which was later put on hold indefinitely by a House committee—drew fire from advocates such as Weismann at R Street Institute. She and other critics pointed out at the time that the bill could ban content around over-the-counter cough syrup and even, potentially, the Colorado governor’s social media posts in favor of the state’s legal psychedelics industry. Under existing regulations, states that have legalized have generally seen less cannabis consumption among young people compared to states where marijuana remains illegal, according to multiple studies. For example, an analysis of government survey data published earlier this year by the advocacy group Marijuana Policy Project (MPP) found that youth marijuana use declined in 19 out of 21 states that legalized adult-use marijuana—with teen cannabis consumption down an average of 35 percent in the first states to legalize a decade ago. The post Bill Advancing In Congress To Protect Kids Online Could Create Complications For Marijuana Businesses In Legal States appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Frequent goes to here i will discuss the obvious way to appreciate it on your attempt, which often is why Now i am viewing the internet site day-to-day, in search of completely new, useful facts. Quite a few, many thanks! 상품권현금화 Certainly great, remarkable, fact-filled tips these. Ones own content articles Be required to fail, thinking that obviously is true these on top of that. One normally generate an intriguing browse. On earth do you enlighten So i'm shocked?: )#) Compete the great articles and reviews. Slot Gacor 777 I had most recently initiated a fabulous web page, the details you will provide you with here comes with really helped others really. Regards just for all of the effort & succeed. sports betting in Canada Helpful — I valued the transparency on player complaint resolution timelines. Quick, fair resolution processes prevent toxic situations from escalating. Real votes showed which teams are responsive. spotbet macau Excellent roundup — I appreciated the filter for low-population but active servers. Smaller communities often offer friendlier vibes and cooperation. Real player rankings showed which small servers thrive. sports betting in Manitoba Excellent list — the server comparison tools simplified my decision. Side-by-side stats like drop rates and population were priceless. Real votes added the final confirmation. sports betting in Quebec Certainly great, remarkable, fact-filled tips these. Ones own content articles Be required to fail, thinking that obviously is true these on top of that. One normally generate an intriguing browse. On earth do you enlighten So i'm shocked?: )#) Compete the great articles and reviews. sports betting in Ontario Frequent goes to here i will discuss the obvious way to appreciate it on your attempt, which often is why Now i am viewing the internet site day-to-day, in search of completely new, useful facts. Quite a few, many thanks! spotbet slot online

May very well just launched some blog page, the knowledge most people furnish on this internet site seems to have made it easier everybody vastly. Thanks a lot for the purpose of your personal instance & give good results. Arquitectura

SCOTUS rejects marijuana case; DOJ: Cannabis users are “greater danger” than alcohol users; Dems push legalization; Senate marijuana banking testimony Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there. Support our work at https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW President Donald Trump said he is “looking…very strongly” at rescheduling marijuana because it would lead to “tremendous amounts of research that can’t be done unless you reclassify.” The U.S. Supreme Court declined to take up a case from marijuana businesses that were attempting to challenge the constitutionality of federal prohibition. The Department of Justice filed a brief in a Supreme Court case on marijuana consumers’ gun rights claiming that people who use cannabis and other illegal drugs “pose a greater danger than users of alcohol.” “Armed drug users pose ‘extraordinary’ ‘hazards,’ as ‘even a momentary lapse’ caused by their ‘impaired perception and judgment’ can result in ‘disastrous consequences.” Key congressional Democrats are arguing that moving marijuana to Schedule III, as President Donald Trump is reportedly considering doing, doesn’t go far enough—with Sen. Ron Wyden (D-OR) saying the president is trying to “gaslight” people into thinking he is legalizing cannabis as part of “an attempt to boost his pathetic approval ratings.” The U.S. Senate Banking Subcommittee on Financial Institutions and Consumer Protection will hear testimony from a former executive director of the Nevada Cannabis Compliance Board on Tuesday at a hearing titled, “Ensuring Fair Access to Banking: Policy Levers and Legislative Solutions.” The latest quarterly tracking poll from Marijuana Moment/NuggMD shows that just 6 percent of cannabis consumers approve of President Donald Trump’s cannabis actions so far—but that 51 percent would support the administration more if it actually rescheduled or legalized marijuana. The National Drug & Alcohol Screening Association is “sounding the alarm” about reports that the Trump administration may reschedule marijuana, hosting an event this week where several GOP members of Congress are expected to raise concerns about the reform. A new study found that a combination of CBD and THC “effectively inhibited ovarian cancer cell growth and invasion.” / FEDERAL President Donald Trump signed an executive order designating fentanyl as a weapon of mass destruction. House Oversight Committee Chairman James Comer (R-KY) said he supports marijuana rescheduling. Nebraska independent Senate candidate Dan Osborn tweeted, “I strongly agree with President Trump that marijuana should be reclassified as a Schedule III drug. This would remove government regulations that have prevented us from learning more about the drug and prevented families from getting the treatment they need.” / STATES Minnesota Gov. Tim Walz (D) signed a cannabis cooperative agreement with the Red Lake Band of Chippewa Indians. Colorado Gov. Jared Polis (D) said he is “glad” the Trump administration is reportedly moving forward with marijuana rescheduling. South Carolina’s attorney general touted enforcement actions against distributors and wholesalers of allegedly illegal THC products that were sold openly in retail stores. The chair of the Idaho House Health and Welfare Committee said he doesn’t think medical cannabis activists will succeed in collecting enough signatures to put a legalization initiative on the ballot. A Kentucky senator authored an op-ed criticizing a new federal law that recriminalizes hemp THC products. A former Guam senator raised concerns that the federal government “can use this rescheduling as a way to prevent state-licensed cannabis cultivators and dispensaries from operating without (Food and Drug Administration) and (Drug Enforcement Administration) licenses to sell a Schedule III drug.” Nevada regulators issued a health and safety bulletin about marijuana products that were treated with an unapproved pesticide. Kansas law enforcement officials are being sued over raids on businesses selling cannabis products. New York regulators announced measures to support businesses transitioning to the state’s new marijuana tracking system. Washington, D.C. officials shut down additional businesses over alleged illegal cannabis sales. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL The Los Angeles, California Police Department settled a lawsuit over a marijuana raid that destroyed an MRI machine. / INTERNATIONAL The German Bundestag is scheduled to consider a bill to alter medical cannabis rules on Thursday. / SCIENCE & HEALTH A study indicated that “cannabis provides temporary relief from symptoms associated” with autism spectrum disorder. A review concluded that “marijuana use is associated with reduced oral cancer risk.” A study of rats found that “a single treatment with a psychedelic is sufficient to elicit very long-lasting behavioral and cellular changes through enduring function plasticity rather than structural plasticity.” / ADVOCACY, OPINION & ANALYSIS Eagle Forum is urging President Donald Trump not to reschedule marijuana. / BUSINESS Canopy Growth Corporation is acquiring MTL Cannabis Corp. IM Cannabis Corp. has a new chief financial officer. Innovative Industrial Properties, Inc. declared a quarterly dividend of $1.90 per share. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: Photo courtesy of Chris Wallis // Side Pocket Images. The post Trump talks cannabis rescheduling at signing ceremony (Newsletter: December 16, 2025) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Frequent goes to here i will discuss the obvious way to appreciate it on your attempt, which often is why Now i am viewing the internet site day-to-day, in search of completely new, useful facts. Quite a few, many thanks! koi toto Certainly great, remarkable, fact-filled tips these. Ones own content articles Be required to fail, thinking that obviously is true these on top of that. One normally generate an intriguing browse. On earth do you enlighten So i'm shocked?: )#) Compete the great articles and reviews. Khao Lak Beach Resort I had most recently initiated a fabulous web page, the details you will provide you with here comes with really helped others really. Regards just for all of the effort & succeed. 토토사이트 주소 Helpful — I valued the transparency on player complaint resolution timelines. Quick, fair resolution processes prevent toxic situations from escalating. Real votes showed which teams are responsive. Forex account management Excellent roundup — I appreciated the filter for low-population but active servers. Smaller communities often offer friendlier vibes and cooperation. Real player rankings showed which small servers thrive. nunflix Excellent list — the server comparison tools simplified my decision. Side-by-side stats like drop rates and population were priceless. Real votes added the final confirmation. paito togel Certainly great, remarkable, fact-filled tips these. Ones own content articles Be required to fail, thinking that obviously is true these on top of that. One normally generate an intriguing browse. On earth do you enlighten So i'm shocked?: )#) Compete the great articles and reviews. Forex managed accounts

Foodle is a word-guessing game with a gastronomic theme. Instead of providing direct clues to your companion, you are required to describe the food in a manner that enables them to identify it. It is both challenging and enjoyable, akin to Wordle and other word games, yet featuring some notable differences.

Whether you’re battling through single-player levels or challenging a friend, Ragdoll Hit offers a delightful mix of strategy, skill, and humor.

What makes basketball stars so engaging is how the streak-based rewards add pressure and excitement, making every match feel meaningful rather than routine.

The in-air braking system in moto x3m encourages experimentation, as players learn how subtle brake control can shift the bike’s angle and dramatically improve landing accuracy.

Experience the power of ayurveda spices and herbs from Yuvika Herbs, the best online ayurvedic store. Their herbal products are lab-tested for quality, making them an ideal option for buying online ayurvedic store. Incorporate these ayurveda herbs into teas or meals for digestion and skin health—highly recommended!

Andahoki adalah pilihan utama bagi para pecinta judi online di Indonesia. Kami menawarkan berbagai permainan judi berkualitas tinggi dan layanan pelanggan terbaik. Bergabunglah sekarang dan nikmati pengalaman judi yang tak terlupakan anda hoki

I truly resonate with Andrea's experience. It’s heartening to see someone pivot their career to promote healthier choices, especially for mothers who face societal pressures. If you're looking for a safe space to explore cannabis products, I highly recommend checking out the Suika Game platform. It’s a community-driven space that encourages exploration and engagement with cannabis culture in a positive light.

Discover Celery Seed magic in Ajmod Benefits: reduces uric acid, eases gout naturally. Apium Graveolens boosts digestion and kidney health. Ajmod Benefits shine for inflammation control. Yuvika Herbs delivers premium Ajmod for your Ayurvedic routine!

In Cowboy Safari, use left/right arrow keys or A/D to dodge obstacles and line up your next daring leap.

Only six percent of marijuana consumers approve of the Trump administration’s actions on cannabis policy to date, according to a new survey that comes as rumors churn that the president intends to direct federal cannabis rescheduling. The latest iteration of a quarterly presidential approval tracking poll from NuggMD and Marijuana Moment also found that 51 percent of respondents would be more likely to embrace the current administration if it rescheduled or legalized marijuana. While some are bullish on recent news that President Donald Trump may move forward with plans to reclassify cannabis as a Schedule III, rather than Schedule I, drug under the Controlled Substances Act, marijuana users’ support for the president’s marijuana “actions” took a dip over the last quarter. Just 1.6 percent of respondents said they “strongly approve” of the actions, 4.5 percent said they approve, a plurality of 38.4 percent were neutral, 26.1 percent disapproved and 29.5 percent strongly disapproved. “Do you approve or disapprove of the presidential administration’s actions on cannabis?” n: % Strongly approve 7 1.6% Approve 20 4.5% No opinion/Neutral 172 38.4% Disapprove 117 26.1% Strongly disapprove 132 29.5% 448 Score (-50 to +50) -19.364 Net approve/disapprove: -49.6% However, the survey data also reinforced the idea that Trump could move the needle among voters who use cannabis if he enacted key reforms such as rescheduling or legalization. It found that, among the respondents, 51 percent said they’d change their level of support for the president if he took action on those reform proposals. Just 1.5 percent said they’d support him less, while a 47.5 percent plurality said their opinion wouldn’t change. “If the Trump administration were to reschedule or legalize cannabis, would that change your level of support for it?” n: % I would support it much more 172 38.4% I would support it a bit more 56 12.5% No change 213 47.5% I would support it a bit less 2 0.4% I would support it much less 5 1.1% 448 Score (-50 to +50): 21.652 Net approve/disapprove: 49.3% “I look at this data as evidence that the White House needs to take tangible action on cannabis rescheduling in order to capture the clear political benefit from the audience we poll, cannabis consumers who participate in state-legal, regulated markets,” Andrew Graham, head of communications at Nugg MD, told Marijuana Moment. “Trial balloons about the imminence of rescheduling won’t cut it,” he said, adding that he doesn’t believe an executive directing a move to Schedule III “solves the many problems with how federal law treats cannabis, a legal substance in many states.” However, “I do think it would benefit the sector and increase access, and that cannabis consumers would notice,” Graham said. The latest quarterly survey showed an overall dip in approval for Trump for those who use marijuana, dropping from 11 percent in the prior quarter to about six percent this quarter. The poll—which involved interviews with 448 frequent cannabis consumers who live in states with legal markets and has a ±4.63 percentage point margin of error—was conducted before it became widely reported that the president planned to move forward on the Biden administration-initiated rescheduling process, with timelines for an action ranging Monday to early next year. Trump on Monday confirmed when asked by a reporter that he is “very strongly” considering rescheduling cannabis, saying the reform “leads to tremendous amounts of research that can’t be done unless you reclassify.” Amid the heightened rescheduling rumors, multiple top congressional Democrats have made the case that the reform would not go far enough—including Sen. Ron Wyden (D-OR) who said the move is only an attempt by the president to “gaslight” voters into thinking he legalized cannabis to boost his “pathetic” approval ratings. Meanwhile, a major drug testing industry organization is “sounding the alarm” amid reports Trump may soon finalize the marijuana rescheduling proposal, arguing that the reform would “have catastrophic consequences for the safety of the United States workforce and transportation sectors.” Cannabis industry stakeholders are holding out hope that the reform will be achieved as soon as possible, but opponents—including the National Drug & Alcohol Screening Association (NDASA) and Smart Approaches to Marijuana (SAM)—are working to dissuade the administration before a final decision is made. For what it’s worth, a White House spokesperson told Marijuana Moment last week that no actions have been finalized so far. Bipartisan congressional lawmakers have been weighing in on the potential rescheduling decision over the past week—with Democrats like Rep. Alex Ocasio-Cortez (D-NY) calling the reform a “no-brainer” and others like Rep. Andy Harris (R-MD) pushing back against the proposal. Trump said in mid-August that he’d be making a decision on rescheduling within weeks. But despite that timeline and the escalating rumors, a White House spokesperson told Marijuana Moment last week that “no final decisions have been made on rescheduling of marijuana.” The Washington Post reported on Thursday evening that Trump was planning to issue an executive order directing federal agencies to move ahead with cannabis rescheduling. The outlet also said the president met earlier this week in the Oval Office with marijuana industry executives, Health and Human Services Secretary Robert F. Kennedy Jr. and Centers for Medicare and Medicaid Services Administrator Mehmet Oz. During that meeting, Trump phoned Johnson, the House speaker, who expressed his opposition to rescheduling cannabis, If the administration does ultimately enact rescheduling, it would mark one of the most significant developments in federal marijuana policy since its prohibition a half a century ago, with a Schedule III reclassification recognizing that marijuana has medical value and a lower abuse potential compared to other Schedule I drugs like heroin. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Trump endorsed rescheduling—as well as industry banking access and a Florida adult-use legalization initiative—on the campaign trail last year. The president had been largely silent on the issue since taking office during his second term, until a briefing in August where in response to a reporter’s question he announced the administration would decide on rescheduling within weeks. The possibility of an imminent rescheduling announcement comes weeks after the president signed a key spending bill that would effectively ban most consumable hemp products, drawing criticism from stakeholders in the hemp industry who argue the policy change would eradicate the market. The post Only Six Percent Of Marijuana Consumers Approve Of Trump’s Reform Actions, But Most Would Shift Opinion If He Reschedules, Poll Finds appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

President Donald Trump on Monday confirmed that the administration is “very strongly” considering a proposal to federally reschedule marijuana because it would boost research into the effects of cannabis. “We are” weighing rescheduling, Trump told reporters after being asked about the issue at an unrelated signing ceremony. He added that “a lot of people want to see it—the reclassification—because it leads to tremendous amounts of research that can’t be done unless you reclassify.” “So we are looking at that very strongly,” he said. The question to the president came amid heightened speculation about a possibly imminent rescheduling decision. CNBC reported it could come as early as Monday, but so far that has not materialized. .@POTUS on marijuana rescheduling: "A lot of people want to see it — the reclassification — because it leads to tremendous amounts of research that can't be done unless you reclassify, so we are looking at that very strongly." pic.twitter.com/Ugych6rLCQ — Rapid Response 47 (@RapidResponse47) December 15, 2025 It remains to be seen whether Trump will fulfill his campaign promise to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA), which would not legalize the plant but would let marijuana businesses take federal tax deductions while removing certain research barriers. He endorsed rescheduling—as well as industry banking access and a Florida adult-use legalization initiative—on the campaign trail last year. But he’s since been largely silent on the issue since taking office during his second term, until a briefing in August where in response to a reporter’s question he announced the administration would decide on rescheduling within weeks. Meanwhile, multiple top congressional Democrats are making the case that the modest reform would not go far enough—including Sen. Ron Wyden (R-OR) who said the move is only an attempt by the president to “gaslight” voters into thinking he legalized cannabis to boost his “pathetic” approval ratings. A major drug testing industry organization separately said it’s “sounding the alarm” amid the reports Trump may soon finalize the rescheduling proposal, arguing that the policy change would “have catastrophic consequences for the safety of the United States workforce and transportation sectors.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Cannabis industry stakeholders are holding out hope that the reform will be achieved as soon as possible, but opponents—including the National Drug & Alcohol Screening Association (NDASA) and Smart Approaches to Marijuana (SAM)—are working to dissuade the administration before a final decision is made. For what it’s worth, a White House spokesperson told Marijuana Moment last week that no actions have been finalized so far. Bipartisan congressional lawmakers have been weighing in on the potential rescheduling decision over the past week—with Democrats like Rep. Alex Ocasio-Cortez (D-NY) calling the reform a “no-brainer” and others like Rep. Andy Harris (R-MD) pushing back against the proposal. Trump said in mid-August that he’d be making a decision on rescheduling within weeks. But despite that timeline and the escalating rumors, a White House spokesperson told Marijuana Moment last week that “no final decisions have been made on rescheduling of marijuana.” The Washington Post reported last week that Trump was planning to issue an executive order directing federal agencies to move ahead with cannabis rescheduling. The outlet also said the president met earlier this week in the Oval Office with marijuana industry executives, Health and Human Services Secretary Robert F. Kennedy Jr. and Centers for Medicare and Medicaid Services Administrator Mehmet Oz. During that meeting, Trump phoned Johnson, the House speaker, who expressed his opposition to rescheduling cannabis, If the administration does ultimately enact rescheduling, it would mark one of the most significant developments in federal marijuana policy since its prohibition a half a century ago, with a Schedule III reclassification recognizing that marijuana has medical value and a lower abuse potential compared to other Schedule I drugs like heroin. The post Trump Says He’s ‘Very Strongly’ Considering Rescheduling Marijuana As Rumors Swell About Imminent Reform appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

This is usually a superb posting, With thanks to get allowing people this review. Continue to keep writing. https://jojoyapp.com.mx/descargar/